First, Cd112 expression in fibrosarcomas was significantly higher in CD155-deficient mice than in WT mice, suggesting that DNAM-1 interaction with CD112 compensated for the loss of the DNAM-1–CD155 interaction. This evidence concerns the gene NECTIN2 and fibrosarcoma.